Q2 Solutions Q2 Solutions Actionable Insights for Better Health and Lab Solutions
Refine Results
Impact of duplicate removal on low frequency NGS somatic variant calling

Cancer genomic profiles created by analysis of targeted Next Generation Sequencing (NGS) panels...

RNA-Seq provides cost-effective alternative for typing self-identifying...

The excitement surrounding immunotherapy is being driven by results in the clinic. Currently...

Genomics enhances Clinical Immuno oncology Trials

Immuno-oncology is developing at an unprecedented rate, with information integrated into drug...

Precision Medicine: Shifting from One Drug for All Trials to Targeted...

The goal of precision medicine is to individualize treatments by tailoring them to the biological...

Systematic Design and Development of the Q2 Solutions Comprehensive Cancer...

A Case Study in Iterative Design and Validation

Gaining Value from your Partner for Biomarker Research and Companion...

Presented at Asian Regional Drug Development Summit on September 9, 2015, this presentation...

Expanding Treatment Options with Genomics-Enabled Immuno-Oncology

Tumor genomic profiling can direct patients to new therapeutic possibilities. Positive responses...

Strategies for Effective Neutralizing Cell Based Assays in Early...

Download this presentation to learn more about the challenges and the importance of neutralizing...

Custom Pooled Human Hepatocytes for Clearance Prediction of Aldehyde...

Activity and scaling approaches for three separate custom pools of cryopreserved human hepatocytes

Identification to Implementation: Partnering with Your Laboratory Through...

Presented at the 2015 World CDx Boston Conference, this presentation will highlight how companion...

Biomarker-Driven Trials: How Laboratory Insight Can Enhance Clinical Trial...

Presented at the 2015 Outsourcing in Clinical Trials New England Conference, this presentation...

Keeping pace with immuno oncology research breakthroughs and biomarker...

The excitement surrounding immuno-oncology is being driven by results seen in the clinic. New...